QCDan Posted April 2, 2020 Share Posted April 2, 2020 Hello hive mind... Anyone seeing interference from study drugs such as Remdesivir on antibody screen testing? We have seen some COVID + patients come up with weak reactivity in LISS and random (non-patterns) in solid phase. These patients were COVID+ and on a drug study for Remdesivir. Link to comment Share on other sites More sharing options...
galvania Posted April 5, 2020 Share Posted April 5, 2020 I'm no longer working but if this is an antibody then it sounds logical that it could cause non-sp results….. Link to comment Share on other sites More sharing options...
Arno Posted April 6, 2020 Share Posted April 6, 2020 Hi, Not aware of such kind of interference with nucleotide analog. It would be more likely if it was with convalescent plasma. Link to comment Share on other sites More sharing options...
Neil Blumberg Posted April 9, 2020 Share Posted April 9, 2020 These patients have a number of potential mechanisms for false positives. Drug is one, and the others are excessive fibrin formation due to DIC and complement activation, which are both seen in seriously ill patients. I assume you are not using anti-complement reagents in your antibody screening, so that is less likely. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now